Onconetix, Inc. (ONCO)

Nasdaq · Pharmaceutical Preparations · Inc. DE

What they're doing

Between 2026-06-21 and 2026-09-19, public records show 2 signals for Onconetix, Inc.. Most notable: 2026-07-29: Filed 8-K disclosing material agreement; 2026-09-14: Filed 8-K disclosing material agreement. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-09-19 from public records.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing material agreement
  2. Material 8-K filing
    Filed 8-K disclosing material agreement
  3. Material 8-K filing
    Filed 8-K disclosing director or officer change
  4. Insider purchase
    HRT FINANCIAL LP (ten_percent_owner) bought $70k of stock
  5. Insider purchase
    HRT FINANCIAL LP (ten_percent_owner) bought $57k of stock
  6. Material 8-K filing
    Filed 8-K disclosing director or officer change
  7. Material 8-K filing
    Filed 8-K disclosing director or officer change
  8. Material 8-K filing
    Filed 8-K disclosing material agreement
  9. Material 8-K filing
    Filed 8-K disclosing director or officer change
  10. Material 8-K filing
    Filed 8-K disclosing material agreement
  11. Material 8-K filing
    Filed 8-K disclosing material agreement
  12. Material 8-K filing
    Filed 8-K disclosing material agreement

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-04-21HRT FINANCIAL LPten percent ownerS49,7100.69$34,300
2026-04-20HRT FINANCIAL LPten percent ownerS94,4620.75$70,847
2026-04-17HRT FINANCIAL LPten percent ownerP34,6360.73$25,284
2026-04-16HRT FINANCIAL LPten percent ownerS53,8670.73$39,323
2026-04-15HRT FINANCIAL LPten percent ownerP92,5540.76$70,341
2026-04-14HRT FINANCIAL LPten percent ownerP74,3500.77$57,250
2025-08-15Oakley Andrew JohndirectorJ200$0
2025-08-15Oakley Andrew JohndirectorA6180$0
2025-08-15Tarsh SimondirectorA6180$0
2025-08-15Tarsh SimondirectorJ390$0
2025-08-15Meier ThomasdirectorA6180$0
2025-08-15Meier ThomasdirectorJ390$0
2025-08-15Ramdeen Timothy R.directorA6180$0
2025-08-15Ramdeen Timothy R.directorJ390$0
2025-07-14Altos Venture AGten percent ownerJ241,514——
2025-03-23Oakley Andrew JohndirectorA1,7090$0
2024-12-20Schiess RalphofficerA177,4620$0
2024-12-20Bruhlmann ChristianofficerA177,4620$0
2024-09-26Tarsh SimondirectorA3,3180$0
2024-09-26SINGH AJITdirectorA3,3180$0
2024-09-26SAPIRSTEIN JAMESdirectorA3,3180$0
2024-09-26Ramdeen Timothy R.directorA3,3180$0
2024-09-26Meier ThomasdirectorA3,3180$0
2024-09-24Bruhlmann ChristianofficerA428,010——
2024-09-24Schiess RalphofficerA489,160——

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings

Onconetix, Inc. (ONCO): insider trades, federal contracts, lobbying | IP Files